SIRT1 and neoplasm: Our present results agree with the previous findings by showing that the SIRT1-inhibition-mediated enhancement of c-Myc acetylation is accompanied by up-regulation of TRAIL and DR5, supporting the idea that SIRT1 plays a tumor-promoting role in the context of c-Myc activation [50,51].